Gerard T. Kennealey

1.5k total citations
27 papers, 1.2k citations indexed

About

Gerard T. Kennealey is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Genetics. According to data from OpenAlex, Gerard T. Kennealey has authored 27 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 13 papers in Oncology and 6 papers in Genetics. Recurrent topics in Gerard T. Kennealey's work include Prostate Cancer Treatment and Research (10 papers), Hormonal and reproductive studies (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Gerard T. Kennealey is often cited by papers focused on Prostate Cancer Treatment and Research (10 papers), Hormonal and reproductive studies (5 papers) and Prostate Cancer Diagnosis and Treatment (5 papers). Gerard T. Kennealey collaborates with scholars based in United States, Canada and United Kingdom. Gerard T. Kennealey's co-authors include Nicholas J. Vogelzang, Mark S. Soloway, E. James Seidmon, Barrie R. Cassileth, Gerald W. Chodak, Norman L. Block, Joseph A. Smith, Paul F. Schellhammer, Sharon D. Luikart and John M. Kirkwood and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer.

In The Last Decade

Gerard T. Kennealey

27 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerard T. Kennealey United States	16	568	400	257	209	146	27	1.2k
Rosario Sacco Italy	24	300 0.5×	253 0.6×	285 1.1×	453 2.2×	58 0.4×	62	1.5k
Sarah Slater United Kingdom	14	650 1.1×	527 1.3×	57 0.2×	170 0.8×	84 0.6×	38	1.1k
David Watkins United Kingdom	22	446 0.8×	747 1.9×	64 0.2×	322 1.5×	47 0.3×	81	1.4k
Gordon Moody United States	11	209 0.4×	303 0.8×	70 0.3×	281 1.3×	60 0.4×	24	836
Grainne M. O’Kane Canada	21	451 0.8×	729 1.8×	64 0.2×	309 1.5×	82 0.6×	121	1.3k
Thomas J. Semrad United States	15	237 0.4×	395 1.0×	40 0.2×	257 1.2×	44 0.3×	51	890
Yan Song United States	20	435 0.8×	613 1.5×	71 0.3×	419 2.0×	26 0.2×	132	1.5k
Hedy Mameghan Australia	20	602 1.1×	254 0.6×	96 0.4×	143 0.7×	21 0.1×	54	1.2k
Jeffrey Kirshner United States	8	757 1.3×	605 1.5×	79 0.3×	131 0.6×	14 0.1×	10	1.4k
F. Shepherd Canada	18	973 1.7×	964 2.4×	61 0.2×	315 1.5×	22 0.2×	48	1.7k

Countries citing papers authored by Gerard T. Kennealey

Since Specialization

Citations

This map shows the geographic impact of Gerard T. Kennealey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard T. Kennealey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard T. Kennealey more than expected).

Fields of papers citing papers by Gerard T. Kennealey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard T. Kennealey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard T. Kennealey. The network helps show where Gerard T. Kennealey may publish in the future.

Co-authorship network of co-authors of Gerard T. Kennealey

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard T. Kennealey. A scholar is included among the top collaborators of Gerard T. Kennealey based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard T. Kennealey. Gerard T. Kennealey is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Shaughnessy, Joyce, Angela DeMichele, X. Cynthia, et al.. (2018). A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated C-reactive protein, a marker of systemic inflammation. Breast Cancer Research and Treatment. 170(3). 547–557. 35 indexed citations

Giaccone, Giuseppe, Rachel E. Sanborn, Saiama N. Waqar, et al.. (2018). A Placebo-Controlled Phase II Study of Ruxolitinib in Combination With Pemetrexed and Cisplatin for First-Line Treatment of Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer and Systemic Inflammation. Clinical Lung Cancer. 19(5). e567–e574. 15 indexed citations

O’Shaughnessy, Joyce, A. DeMichele, X. Cynthia, et al.. (2017). Abstract P4-22-04: A randomized, double-blind, phase 2 study of ruxolitinib (RUX) or placebo (PBO) in combination with capecitabine (CAPE) in patients (pts) with advanced HER2-negative breast cancer (ABC) and elevated C-reactive protein (CRP), a marker of systemic inflammation. Cancer Research. 77(4_Supplement). P4–22. 1 indexed citations

Kolibaba, Kathryn S., et al.. (2013). Therapeutic Advances in Hematology. 9 indexed citations

Mahalingam, Devalingam, John Sarantopoulos, Santiago Aparo, et al.. (2012). 555 A Study of REOLYSIN in Combination with Gemcitabine in Patients with Advanced Pancreatic Adenocarcinoma. European Journal of Cancer. 48. 170–171. 3 indexed citations

Gish, Robert G., Camillo Porta, Paul Ruff, et al.. (2006). 28 Results of a phase iii randomized controlled study comparing the survival of patients with unresectable hepatocellular carcinoma (HCC) treated with nolatrexed (NOL) or doxorubicin (DOX). Journal of Hepatology. 44. S13–S13. 8 indexed citations

Grous, John, et al.. (2003). 825 Statistical analysis of survival in patients with advanced non-small-cell lung cancer (NSCLC) treated with gefitinib (‘Iressa’, ZD1839) in an expanded access program (EAP): preliminary results. European Journal of Cancer Supplements. 1(5). S248–S248. 4 indexed citations

Clarke, Stephen, M. de Boer, Jaco J. Verweij, et al.. (1996). Phase I trial of ZD1694, a new folate-based thymidylate synthase inhibitor, in patients with solid tumors.. Journal of Clinical Oncology. 14(5). 1495–1503. 67 indexed citations

Cunningham, David, John Zalcberg, I E Smith, et al.. (1996). ‘Tomudex’ (ZD1694) : A novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. Annals of Oncology. 7(2). 179–182. 45 indexed citations

10.

Chodak, Gerald W., et al.. (1995). Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinoma. Urology. 46(6). 849–855. 66 indexed citations

11.

Vogelzang, Nicholas J., Gerald W. Chodak, Mark S. Soloway, et al.. (1995). Goserelin versus orchiectomy in the treatment of advanced prostate cancer: Final results of a randomized trial. Urology. 46(2). 220–226. 130 indexed citations

12.

Soloway, Mark S., et al.. (1995). Bicalutamide in the Treatment of Advanced Prostatic Carcinoma: A Phase II Noncomparative Multicenter Trial Evaluating Safety, Efficacy and Long-Term Endocrine Effects of Monotherapy. The Journal of Urology. 154(6). 2110–2114. 24 indexed citations

13.

Matzkin, Haim, Mark S. Soloway, Paul F. Schellhammer, et al.. (1993). Prognostic factors in stage D2 prostate cancer treated with a pure nonsteroidal antiandrogen. Cancer. 72(4). 1286–1290. 37 indexed citations

14.

Cassileth, Barrie R., Mark S. Soloway, Nicholas J. Vogelzang, et al.. (1992). Quality of life and psychosocial status in stage D prostate cancer. Quality of Life Research. 1(5). 323–330. 124 indexed citations

15.

Vogelzang, Nicholas J. & Gerard T. Kennealey. (1992). Recent developments in endocrine treatment of prostate cancer.. PubMed. 70(4 Suppl). 966–76. 22 indexed citations

16.

Citrin, Dennis L., et al.. (1991). A comparison of Zoladex® and DES in the treatment of advanced prostate cancer: Results of a randomized, multicenter trial. The Prostate. 18(2). 139–146. 28 indexed citations

17.

Cassileth, Barrie R., et al.. (1989). Patients' choice of treatment in stage D prostate cancer. Urology. 33(5). 57–62. 173 indexed citations

18.

Luikart, Sharon D., Gerard T. Kennealey, & John M. Kirkwood. (1984). Randomized phase III trial of vinblastine, bleomycin, and cis-dichlorodiammine-platinum versus dacarbazine in malignant melanoma.. Journal of Clinical Oncology. 2(3). 164–168. 75 indexed citations

19.

Kennealey, Gerard T.. (1978). Sjögren's Syndrome With Pseudolymphoma 13 Years After Hodgkin's Disease. Archives of Internal Medicine. 138(4). 635–635. 11 indexed citations

20.

Kennealey, Gerard T.. (1978). Sjogren's syndrome with pseudolymphoma 13 years after Hodgkin's disease. Archives of Internal Medicine. 138(4). 635–636. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact